Green Cross, a South Korean biopharmaceutical company, today announced that it had signed MOU on the 6th of March with the Guizhou provincial government of China for the investment in the cell therapy sector in China.
from The Medical News http://ift.tt/1b2rGOL
from The Medical News http://ift.tt/1b2rGOL
No comments:
Post a Comment